Market Closed -
Japan Exchange
06:57:10 17/05/2024 BST
|
5-day change
|
1st Jan Change
|
3,865
JPY
|
+0.39%
|
|
+1.05%
|
+4.46%
|
Fiscal Period: September |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
3,370
|
2,817
|
3,127
|
3,146
|
2,901
|
3,356
|
Enterprise Value (EV)
1 |
2,996
|
3,385
|
3,175
|
3,059
|
2,088
|
1,735
|
P/E ratio
|
11
x
|
12.7
x
|
8.28
x
|
6.12
x
|
4.42
x
|
6.04
x
|
Yield
|
2.5%
|
3%
|
2.69%
|
3.04%
|
3.57%
|
2.82%
|
Capitalization / Revenue
|
0.11
x
|
0.09
x
|
0.1
x
|
0.09
x
|
0.08
x
|
0.1
x
|
EV / Revenue
|
0.09
x
|
0.11
x
|
0.1
x
|
0.08
x
|
0.06
x
|
0.05
x
|
EV / EBITDA
|
7.82
x
|
9
x
|
7.09
x
|
3.8
x
|
2.02
x
|
2.09
x
|
EV / FCF
|
-31
x
|
-3.89
x
|
8.87
x
|
15.4
x
|
2.96
x
|
2.02
x
|
FCF Yield
|
-3.22%
|
-25.7%
|
11.3%
|
6.5%
|
33.8%
|
49.4%
|
Price to Book
|
0.64
x
|
0.53
x
|
0.56
x
|
0.51
x
|
0.44
x
|
0.47
x
|
Nbr of stocks (in thousands)
|
937
|
937
|
933
|
912
|
901
|
901
|
Reference price
2 |
3,595
|
3,005
|
3,350
|
3,450
|
3,220
|
3,725
|
Announcement Date
|
21/12/18
|
20/12/19
|
18/12/20
|
21/12/21
|
21/12/22
|
21/12/23
|
Fiscal Period: September |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
31,730
|
31,013
|
31,040
|
36,221
|
37,333
|
35,094
|
EBITDA
1 |
383
|
376
|
448
|
805
|
1,035
|
830
|
EBIT
1 |
293
|
283
|
361
|
713
|
944
|
751
|
Operating Margin
|
0.92%
|
0.91%
|
1.16%
|
1.97%
|
2.53%
|
2.14%
|
Earnings before Tax (EBT)
1 |
472
|
333
|
570
|
746
|
973
|
804
|
Net income
1 |
305
|
221
|
378
|
516
|
657
|
556
|
Net margin
|
0.96%
|
0.71%
|
1.22%
|
1.42%
|
1.76%
|
1.58%
|
EPS
2 |
325.4
|
235.8
|
404.4
|
564.1
|
728.1
|
617.1
|
Free Cash Flow
1 |
-96.5
|
-870.4
|
358
|
199
|
706.4
|
857.1
|
FCF margin
|
-0.3%
|
-2.81%
|
1.15%
|
0.55%
|
1.89%
|
2.44%
|
FCF Conversion (EBITDA)
|
-
|
-
|
79.91%
|
24.72%
|
68.25%
|
103.27%
|
FCF Conversion (Net income)
|
-
|
-
|
94.71%
|
38.57%
|
107.52%
|
154.16%
|
Dividend per Share
2 |
90.00
|
90.00
|
90.00
|
105.0
|
115.0
|
105.0
|
Announcement Date
|
21/12/18
|
20/12/19
|
18/12/20
|
21/12/21
|
21/12/22
|
21/12/23
|
Fiscal Period: September |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
568
|
48
|
-
|
-
|
-
|
Net Cash position
1 |
374
|
-
|
-
|
87
|
813
|
1,621
|
Leverage (Debt/EBITDA)
|
-
|
1.511
x
|
0.1071
x
|
-
|
-
|
-
|
Free Cash Flow
1 |
-96.5
|
-870
|
358
|
199
|
706
|
857
|
ROE (net income / shareholders' equity)
|
6.33%
|
4.16%
|
6.96%
|
8.98%
|
10.5%
|
8.12%
|
ROA (Net income/ Total Assets)
|
1.2%
|
1.17%
|
1.54%
|
2.9%
|
3.51%
|
2.58%
|
Assets
1 |
25,402
|
18,928
|
24,576
|
17,783
|
18,734
|
21,582
|
Book Value Per Share
2 |
5,636
|
5,692
|
6,023
|
6,829
|
7,329
|
7,970
|
Cash Flow per Share
2 |
1,724
|
745.0
|
824.0
|
876.0
|
1,562
|
2,436
|
Capex
1 |
341
|
90
|
52
|
31
|
24
|
101
|
Capex / Sales
|
1.07%
|
0.29%
|
0.17%
|
0.09%
|
0.06%
|
0.29%
|
Announcement Date
|
21/12/18
|
20/12/19
|
18/12/20
|
21/12/21
|
21/12/22
|
21/12/23
|
|
1st Jan change
|
Capi.
|
---|
| +4.46% | 22.4M | | +5.41% | 106B | | -3.11% | 64.74B | | +73.33% | 49.34B | | +17.24% | 39.15B | | +6.13% | 32.86B | | +12.77% | 20.29B | | +15.03% | 17.21B | | +19.06% | 15.28B | | +6.28% | 14.58B |
Other Commodity Chemicals
|